Becker's Healthcare October 29, 2025
Centene reported a $6.6 billion loss in 2025’s third quarter but landed $49.7 billion in revenue, the company shared in its Oct. 29 earnings release.
The company cited the One Big Beautiful Bill Act and a dip in its stock as drivers behind a quantitative goodwill impairment analysis, which is a comparison of a reporting unit’s fair value and its book value. Centene noted a noncash goodwill impairment of $6.7 billion.
Revenues increased 18.2% year over year. The company also increased its full-year outlook, upping its forecast for adjusted diluted earnings per share by $0.25 to reach at least $2.
“Our third-quarter results and increased full-year outlook demonstrate tangible progress against the near-term milestones we laid out for investors in...







